AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis
Authors: Weber, S Schneider, L Peters, M Misselwitz, J Ronnefarth, G Boswald, M Bonzel, KE Seeman, T Sulakova, T Kuwertz-Broking, E Gregoric, A Palcoux, JB Tasic, V Manz, F Scharer, K Seyberth, HW Konrad, M
Citation: S. Weber et al., Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis, J AM S NEPH, 12(9), 2001, pp. 1872-1881
Primary gene structure and expression studies of rodent paracellin-1
Authors: Weber, S Schlingmann, KP Peters, M Nejsum, LN Nielsen, S Engel, H Grzeschik, KH Seyberth, HW Grone, HJ Nusing, R Konrad, M
Citation: S. Weber et al., Primary gene structure and expression studies of rodent paracellin-1, J AM S NEPH, 12(12), 2001, pp. 2664-2672
Hereditary hypokalemic salt-losing tubulopathies: Bartter-like syndromes
Authors: Peters, M Jeck, N Seyberth, HW Konrad, M
Citation: M. Peters et al., Hereditary hypokalemic salt-losing tubulopathies: Bartter-like syndromes, CONTR NEPHR, 136, 2001, pp. 157-173
Effect of preterm formula with and without long-chain polyunsaturated fatty acids on the urinary excretion of F-2-isoprostanes and 8-epi-prostaglandin F-2 alpha
Authors: Stier, C Schweer, H Jelinek, J Watzer, B Seyberth, HW Leonhardt, A
Citation: C. Stier et al., Effect of preterm formula with and without long-chain polyunsaturated fatty acids on the urinary excretion of F-2-isoprostanes and 8-epi-prostaglandin F-2 alpha, J PED GASTR, 32(2), 2001, pp. 137-141
Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome
Authors: Jeck, N Derst, C Wischmeyer, E Ott, H Weber, S Rudin, C Seyberth, HW Daut, J Karschin, A Konrad, M
Citation: N. Jeck et al., Functional heterogeneity of ROMK mutations linked to hyperprostaglandin E syndrome, KIDNEY INT, 59(5), 2001, pp. 1803-1811
Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression
Authors: Kammerl, MC Nusing, RM Seyberth, HW Riegger, GAJ Kurtz, A Kramer, BK
Citation: Mc. Kammerl et al., Inhibition of cyclooxygenase-2 attenuates urinary prostanoid excretion without affecting renal renin expression, PFLUG ARCH, 442(6), 2001, pp. 842-847
Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness
Authors: Jeck, N Reinalter, SC Henne, T Marg, W Mallmann, R Pasel, K Vollmer, M Klaus, G Leonhardt, A Seyberth, HW Konrad, M
Citation: N. Jeck et al., Hypokalemic salt-losing tubulopathy with chronic renal failure and sensorineural deafness, PEDIATRICS, 108(1), 2001, pp. NIL_23-NIL_31
Editorial
Authors: Reinhardt, D Seyberth, HW
Citation: D. Reinhardt et Hw. Seyberth, Editorial, MONATS KIND, 149(9), 2001, pp. 933-933
New section: Pharmacotherapy in childhood
Authors: Reinhardt, D Seyberth, HW
Citation: D. Reinhardt et Hw. Seyberth, New section: Pharmacotherapy in childhood, MONATS KIND, 149(7), 2001, pp. 698-698
Recommendations of the working group for pediatric rheumatology on therapywith etanercept. Commission for pharmacotherapy
Authors: Horneff, G Forster, J Seyberth, HW Michels, H
Citation: G. Horneff et al., Recommendations of the working group for pediatric rheumatology on therapywith etanercept. Commission for pharmacotherapy, MONATS KIND, 149(10), 2001, pp. 1066-1069
Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies
Authors: Reinalter, SC Grone, HJ Konrad, M Seyberth, HW Klaus, G
Citation: Sc. Reinalter et al., Evaluation of long-term treatment with indomethacin in hereditary hypokalemic salt-losing tubulopathies, J PEDIAT, 139(3), 2001, pp. 398-406
Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: Therapeutic use of the cyclooxygenase-2 inhibitor nimesulide
Authors: Nusing, RM Reinalter, SC Peters, M Komhoff, M Seyberth, HW
Citation: Rm. Nusing et al., Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: Therapeutic use of the cyclooxygenase-2 inhibitor nimesulide, CLIN PHARM, 70(4), 2001, pp. 384-390
Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome
Authors: Konrad, M Vollmer, M Lemmink, HH Van den Heuvel, LPWJ Jeck, N Vargas-Poussou, R Lakings, A Ruf, R Deschenes, G Antignac, C Guay-Woodford, L Knoers, NVAM Seyberth, HW Feldmann, D Hildebrandt, F
Citation: M. Konrad et al., Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome, J AM S NEPH, 11(8), 2000, pp. 1449-1459
Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene
Authors: Weber, S Hoffmann, K Jeck, N Saar, K Boeswald, M Kuwertz-Broeking, E Meij, IIC Knoers, NVAM Cochat, P Sulakova, T Bonzel, KE Soergel, M Manz, F Schaerer, K Seyberth, HW Reis, A Konrad, M
Citation: S. Weber et al., Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene, EUR J HUM G, 8(6), 2000, pp. 414-422
Determination of free and glucuronide conjugated 20-hydroxy-arachidonic acid (20-HETE) in urine by gas chromatography/negative ion chemical ionization mass spectrometry
Authors: Watzer, B Reinalter, S Seyberth, HW Schweer, H
Citation: B. Watzer et al., Determination of free and glucuronide conjugated 20-hydroxy-arachidonic acid (20-HETE) in urine by gas chromatography/negative ion chemical ionization mass spectrometry, PROS LEUK E, 62(3), 2000, pp. 175-181
Antenatal Bartter syndrome with sensorineural deafness: refinement of the locus on chromosome 1p31
Authors: Vollmer, M Jeck, N Lemmink, HH Vargas, R Feldmann, D Konrad, M Beekmann, F van den Heuvel, LPWJ Deschenes, G Guay-Woodford, LM Antignac, C Seyberth, HW Hildebrandt, F Knoers, NVAM
Citation: M. Vollmer et al., Antenatal Bartter syndrome with sensorineural deafness: refinement of the locus on chromosome 1p31, NEPH DIAL T, 15(7), 2000, pp. 970-974
The diuretic- and Bartter-like salt-losing tubulopathies
Authors: Jeck, N Konrad, M Hess, M Seyberth, HW
Citation: N. Jeck et al., The diuretic- and Bartter-like salt-losing tubulopathies, NEPH DIAL T, 15, 2000, pp. 19-20
Treatment of Etanercept (P75 TNF-alpha-receptor immunoglobulin fusion protein) - Recommendations of the Kommission Pharmakotherapie
Authors: Horneff, G Forster, J Seyberth, HW Michels, H
Citation: G. Horneff et al., Treatment of Etanercept (P75 TNF-alpha-receptor immunoglobulin fusion protein) - Recommendations of the Kommission Pharmakotherapie, Z RHEUMATOL, 59(6), 2000, pp. 365-369
Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome
Authors: Komhoff, M Jeck, NDM Seyberth, HW Grone, HJ Nusing, RM Breyer, MD
Citation: M. Komhoff et al., Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome, KIDNEY INT, 58(6), 2000, pp. 2420-2424
Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype
Authors: Jeck, N Konrad, M Peters, M Weber, S Bonzel, KE Seyberth, HW
Citation: N. Jeck et al., Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype, PEDIAT RES, 48(6), 2000, pp. 754-758
Use of medicine without authorization or without authorization in children
Authors: Knoppel, C Klinger, O Soergel, M Seyberth, HW Leonhardt, A
Citation: C. Knoppel et al., Use of medicine without authorization or without authorization in children, MONATS KIND, 148(10), 2000, pp. 904-908
Effect of hydroxyeicosatetraenoic acids on furosemide-sensitive chloride secretion in rat distal colon
Authors: Wegmann, M Kampen, A Weber, S Seyberth, HW Kockerling, A
Citation: M. Wegmann et al., Effect of hydroxyeicosatetraenoic acids on furosemide-sensitive chloride secretion in rat distal colon, J PHARM EXP, 295(1), 2000, pp. 133-138
Hereditary hypokalemic salt-losing tubulopathies
Authors: Jeck, N Konrad, M Seyberth, HW
Citation: N. Jeck et al., Hereditary hypokalemic salt-losing tubulopathies, CHANNELOPATHIES - COMMON MECHANISMS IN AURA, ARRHYTHMIA AND ALKALOSIS, 2000, pp. 327-354
Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatorydrugs
Authors: Girschick, HJ Seyberth, HW Huppertz, HI
Citation: Hj. Girschick et al., Treatment of childhood hypophosphatasia with nonsteroidal antiinflammatorydrugs, BONE, 25(5), 1999, pp. 603-607
Pharmacokinetics of alprostadil (prostaglandin E-1) in patients undergoinghaemodialysis
Authors: Cawello, W Kuhlmann, U Schweer, H Samadi, N Gerloff, J Wilberz, S Seyberth, HW Lange, H
Citation: W. Cawello et al., Pharmacokinetics of alprostadil (prostaglandin E-1) in patients undergoinghaemodialysis, CLIN DRUG I, 18(4), 1999, pp. 279-285
Risultati: 1-25 | 26-28